Literature DB >> 8730201

Wegener granulomatosis: CT and MR findings.

J M Provenzale1, N B Allen.   

Abstract

PURPOSE: To demonstrate the spectrum of CT and MR imaging findings in patients with Wegener granulomatosis and to determine how often these findings could be attributed to either direct extension from paranasal or orbital disease sites, remote granulomas, or central nervous system (CNS) vasculitis.
METHODS: We retrospectively reviewed the CT or MR studies of 15 patients with Wegener granulomatosis.
RESULTS: Abnormal findings were seen in 7 patients (5 examined with MR imaging, 2 with CT). Findings included dural thickening and contrast enhancement (3 patients), infarcts (2 patients), regions of hyperintense signal on T2-weighted MR images (2 patients), and abnormal MR signal in the brain stem (2 patients). Three patients with imaging findings of dural enhancement and thickening were thought to have remote granulomatous lesions involving the dura. No patients had extension from sites external to the CNS or clinical findings suggestive of CNS vasculitis.
CONCLUSION: The spectrum of CT and MR findings in Wegener granulomatosis includes dural thickening and enhancements cerebral infarction, and MR signal abnormalities in the brain stem and white matter. Presumed remote granulomatous lesions were the most common causes of CNS findings in this study. Complications related to non-CNS disease (eg, hypertension, endocarditis) also appear to have played a role in some patients.

Entities:  

Mesh:

Year:  1996        PMID: 8730201      PMCID: PMC8337270     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  15 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  MR imaging findings of spinal dural involvement with Wegener granulomatosis.

Authors:  Sait Albayram; Osman Kizilkilie; Ibrahim Adaletli; Nuray Erdogan; Naci Kocer; Civan Islak
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

3.  MR Imaging in Wegener granulomatosis of the spinal cord.

Authors:  Hans-J Mentzel; Thomas Neumann; Clemens Fitzek; Dieter Sauner; Jürgen R Reichenbach; Werner A Kaiser
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

4.  Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis.

Authors:  Radek Spísek; Elena Kolouchová; Jirí Jensovský; Robert Rusina; Pavel Fendrych; Jaroslav Plas; Jirina Bartůnková
Journal:  Clin Rheumatol       Date:  2005-12-02       Impact factor: 2.980

5.  Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study.

Authors:  M Rovaris; B Viti; G Ciboddo; S Gerevini; R Capra; G Iannucci; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

6.  [Imaging procedures in rheumatology: imaging in vasculitis].

Authors:  W A Schmidt; M Both; E Reinhold-Keller
Journal:  Z Rheumatol       Date:  2006-11       Impact factor: 1.372

7.  Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis.

Authors:  Hyun Ah Choi; Mi Ji Lee; Chin-Sang Chung
Journal:  J Neurol       Date:  2017-02-20       Impact factor: 4.849

8.  Radiolabeled leucocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies).

Authors:  J M Murphy; K K Balan; A Toms; B Gomez-Anson; M Lockwood
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

9.  Chest CT findings in pediatric Wegener's granulomatosis.

Authors:  Daniel Levine; Jonathan Akikusa; David Manson; Earl Silverman; Rayfel Schneider
Journal:  Pediatr Radiol       Date:  2006-10-28

10.  Wegener granuloma in the fourth ventricle.

Authors:  Ansgar Berlis; Franziska Petschner; Ingolf Carl Bötefür; Joachim Spreer
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.